Molecular Pharmaceutics and Drug Delivery professor Maria A. Croyle, Ph.D. earned this year's Best Paper Award from the University Co-op Research Excellence Awards, presented by UT's Office of the Vice President for Research, Scholarship and Creative Endeavors and the University Co-operative Society.
The Cancer Prevention and Research Institute of Texas (CPRIT) has released its grant research funding awards for the upcoming year. All three awarded research projects at The University of Texas at Austin involve College of Pharmacy faculty.
This year, college welcomes Daniel San Miguel and Adriana Vargus through the BOOT program, providing a generous 12-month stipend plus paid tuition for the first academic year in order to to increase the recruitment, retention and preparation of trainees from diverse backgrounds.
Pharmacy schools across the country completed their 2022 Phase I and Phase II residency matches for new or upcoming graduates of their Doctor of Pharmacy (Pharm.D.) programs. The University of Texas at Austin College of Pharmacy placed in the top ten of all pharmacy schools in the nation, and number one in Texas.
Two of the college's distinguished faculty in the Division of Pharmacotherapy were recommended for promotion by President Hartzell. Dr. Kelly R. Reveles will assume the rank of associate professor and Dr. Kirk Evoy will become a clinical associate professor. Both promotions go into effect September 1, 2022.
The UT College of Pharmacy Alumni Association has selected Benjamin McNabb, Pharm.D., Julie Johnson, Pharm.D. and Jeanne D. Waggener, R.Ph. as the 2021 Alumni Award recipients. 2020 and 2021 Alumni Award winners will be honored on November 13, 2021 at the Pharmacy Homecoming Tailgate, generously sponsored by H-E-B.
A paper from UT College of Pharmacy researchers was awarded the 2021 Outstanding Paper of the Year from the American College of Clinical Pharmacy (ACCP) Ambulatory Care Practice Research Network. The paper investigates the availability of buprenorphine and naloxone in Texas to treat opioid use disorder.
The College of Pharmacy’s Pharmaceutical Engineering and 3D Printing (PharmE3D) Labs recently earned a three-year $1.5 million National Institutes of Health (NIH) R01 grant to research novel manufacturing technology for complex vaccine formulations for influenza and other emerging infectious diseases.
Somshuvra Mukhopadhyay, M.B.B.S., Ph.D., associate professor in the Division of Pharmacology and Toxicology and Hamm Centennial Fellow in Pharmacy, and a team of researchers have released new findings defining the first homeostatic regulatory pathway for manganese in mammalian systems. Identifying these pathways opens up new possible options to prevent or treat manganese-induced parkinsonism and other disorders linked to elevated manganese exposure.